Mayo Clinic Talks

Advanced Directives in Healthcare

Guest: Janet Vittone, M.D.

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

Janet Vittone, M.D., outlines the difference between different advanced directive documents and the importance of discussing these with all of your patients. She shares tips on when and how to broach the topic with patients, especially those in early adulthood. Drs. Vittone and Chutka also discuss ensuring that the right people are aware of your wishes, should you become incapacitated.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Deeper Dive:

• Living wills and advance directives for medical decisions, by Mayo Clinic: https://www.mayoclinic.org/healthy-lifestyle/consumer-health/in-depth/living-wills/art-20046303
• Patient education video: https://www.mayoclinic.org/healthy-lifestyle/consumer-health/multimedia/advance-directives-awarness/vid-20114292

COVID-19 Miniseries Episode 11: Mayo Clinic Q&A - Antibody Testing and Collaboration in Science

This episode is shared from Mayo Clinic Q&A and was recorded on April 3, 2020. 

To claim credit visit: https://ce.mayo.edu/covid19podcast 

Guest:  Gregory A. Poland, M.D.  (@drgregpoland) 

Host: Halena M. Gazelka, M.D. (@hmgazelkamd) 

Dr. Greg Poland returns to share an update on the COVID-19 pandemic in this episode shared from Mayo Clinic Q&A to discuss the latest in antibody testing, coronavirus immunity, and whether or not it’s safe to wear contact lenses. 

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

COVID-19 Miniseries Episode 10: How to Mitigate Drug-Induced Sudden Cardiac Death From Hydroxychloroquine

This episode was recorded on April 3, 2020

Claim credit here: https://ce.mayo.edu/covid19podcast

Guest:  Michael J. Ackerman, M.D., Ph.D. (@MJAckermanMDPhD)

Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006)

The administration of hydroxychloroquine and azithromycin, along with other very common medications could result in drug-induced sudden cardiac death caused by drug-induced QT prolongation, in some patients. In order to avoid the wrong medication, for the wrong patient, at the wrong time, Dr. Michael Ackerman shares how to assess your patient’s risk, how to find and measure their QTc value, and neutralize the threat.

Deeper Dive:

• Link to Journal Pre-Proof:
  https://mayoclinicproceedings.org/pb/assets/raw/Health%20Advance/journals/jmcp/jmcp_covid19.pdf
• Link to COVID-19 QTc Calculator and other resources:
  https://www.covidqtc.com/#WRchTxt7-12ve

Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ. Urgent guidance for navigating and circumventing the QTc prolonging and torsadogenic potential of possible pharmacotherapies for COVID-19 [published online ahead of print March 25, 2020]. Mayo Clin Proc. https://doi.org/10.1016/j.mayocp.2020.03.024.

• FDA Emergency Use Authorization (EUA) of hydroxychloroquine sulfate: https://www.fda.gov/media/136538/download
• Mayo Clinic Connected Care - Genetic Heart Rhythm Diseases https://connect.mayoclinic.org/page/genetic-heart-rhythm-disorders/tab/covid-19/#

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Mayo Clinic Q&A: The ‘Unprecedented Challenge’ of Fighting COVID-19

This episode is shared from Mayo Clinic Q&A.

Guest: Elie Berbari, MD (@DODElie)

Host: Tom Shives, MD and Tracy McCray (@TracyMcCray)

The ongoing fight against the COVID-19 pandemic has heavily burdened front-line health care providers. "Our nation and our medical community is facing an unprecedented challenge," says Dr. Elie Berbari, chair of the Division of Infectious Diseases at Mayo Clinic. 

On the Mayo Clinic Q&A podcast, Dr. Berbari discusses how Mayo Clinic is minimizing exposure to staff, while providing safe and compassionate care to patients. 

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Mayo Clinic Q&A: How Does SARS-CoV-2 Make People Sick?

This episode is shared from Mayo Clinic Q&A and was recorded on March 31, 2020.

Guest:  Gregory Poland, M.D.

Host: Sanjeev (Sanj) Kakar, M.D. (@sanjkakar)

A novel coronavirus is a new strain that has not been seen before in humans. SARS-Co-V2 is a novel virus, causing the disease COVID-19. Because COVID-19 is a new disease, much is still being learned about how it spreads and the severity of illness it causes. 

On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, infectious disease expert and head of Mayo Clinic’s Vaccine Research Group, explains the science behind how the virus makes people sick, and what the virus does to the body. Dr. Poland will also discuss the latest information on clinical trials and vaccine research to fight the disease outbreak.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

A Rheumatologist’s Approach to Osteoarthritis

Guest: Alicia M. Hinze, M.D., M.H.S. (@alicia_hinze)

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

Alicia M. Hinze, M.D., M.H.S., provides an overview of osteoarthritis and other rheumatologic conditions. Dr. Hinze shares her approach to distinguishing between osteoarthritis and inflammatory arthritis, along with risk factors for developing osteoarthritis over time, including genetics, professions, prior injuries, and age. She shares recommendations for conservative therapies and at what point surgical intervention should be considered.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

COVID-19 Miniseries Episode 9: Recommendations on Ibuprofen

This episode was recorded on Monday, March 30, 2020.

Claim credit here: https://ce.mayo.edu/covid19podcast

Guest:  Matthew P. Van Cuyk, Pharm.D., R.Ph. 

Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006) 

Should we be using ibuprofen to treat patients with COVID-19? Does this fall into the modifiable risk category? Dr. Matthew Van Cuyk breaks down recent events and literature around ibuprofen use in patients with COVID-19. 

Deeper Dive:

1. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory Medicine. March 2020. https://doi.org/10.1016/S2213-2600(20)30116-8
2. HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19
3. ASHP Coronavirus Resource Center: https://www.ashp.org/Pharmacy-Practice/Resource-Centers/Coronavirus
4. Assessment of Evidence for COVID-19-Related Treatments: Updated 3/27/2020

For the most up to date COVID-19 information:

• CDC: https://www.cdc.gov/coronavirus/2019-ncov/index.html
• WHO: https://www.who.int/emergencies/diseases/novel-coronavirus-2019

Mayo Clinic Q&A: Point-of-Care Manufacturing to Help Fight COVID-19

This episode is shared from Mayo Clinic Q&A and was recorded on March 26, 2020.

Guest:  Jonathan M. Morris, M.D. & Mark Wehde

Host: Tom Shives, MD and Tracy McCray (@TracyMcCray)

When it comes to fighting the COVID-19 pandemic, Mayo Clinic is relying not only on clinicians, but also engineers. Supply chain management and manufacturing capabilities are being readied to help in the fight against COVID-19.

On the Mayo Clinic Q&A podcast, Dr. Jonathan Morris, co-director of Mayo Clinic's 3D Anatomic Modeling Lab, and Mark Wehde, chair of Mayo Clinic's Division of Engineering, discuss personal protective equipment and mobilizing the manufacturing sector to help in the fight. They’ll share how they’re utilizing 3D printing to jump start conventional scalable manufacturing processes to retro-engineer pieces of respiratory equipment and solve today’s problems in the fight against COVID-19.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

COVID-19 Miniseries Episode 8: Azithromycin and Hydroxychloroquine

This episode was recorded on March 27, 2020.

To claim credit visit: https://ce.mayo.edu/covid19podcast

Guest: Christina G. Rivera, Pharm.D., R.Ph.; Ryan W. Stevens, Pharm.D. (@Stevens_AK)

Host: Raymund R. Razonable, M.D. (@RazonableMD)

Chloroquine emerged as an early COVID-19 treatment option in China and there has been increasing interest in the use of hydroxychloroquine and azithromycin. What data is available for the safety and efficacy of the drugs in the fight against SARS-CoV-2? Dr. Christina Rivera and Dr. Ryan Stevens provide a breakdown of recent research.

Deeper Dive:

1. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents. March 2020. https://doi.org/10.1016/j.ijantimicag.2020.105949
2. Yao X, Ye F, Zhang M, et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clinical Infectious Diseases. March 2020. https://doi.org/10.1093/cid/ciaa237
3. Guidance on patients at risk of drug-induced sudden cardiac death from off-label COVID-19 treatments https://mayocl.in/2WQhxzI

For the most up to date COVID-19 information:

• CDC: https://www.cdc.gov/coronavirus/2019-ncov/index.html
• WHO: https://www.who.int/emergencies/diseases/novel-coronavirus-2019

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Mayo Clinic Q&A: Shifting from Me to We

This episode is shared from Mayo Clinic Q&A and was recorded on March 25, 2020.

Guest: Greg Poland, MD (@drgregpoland)

Host: Tom Shives, MD and Tracy McCray (@TracyMcCray)

Greg Poland, MD, answers trending questions from listeners. Is it safe to order take-out or have groceries delivered? Can pets get coronavirus? What about our summer plans? What’s next for social distancing and is it working?

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Opioid Edition 10: Side Effects Management

Guest: Molly A. Feely, M.D. (@mollyfeelymd)

Host: Tracy McCray

Episode 10 of 10: Dr. Molly Feely, who is board-certified in palliative care, internal medicine, and family medicine now practicing full-time palliative care at Mayo Clinic in Rochester, talks about best practices for Management of Opioid Side Effects. 

Claim CME credit at ce.mayo.edu/opioidpc. This episode is required to be compliant with controlled substance prescribing guidelines in the state of Minnesota.

Episode transcript: https://mcdn.podbean.com/mf/web/gt8znj/Ep_27-Opioid_Edition_10_Side_Effects_Management.pdf

COVID-19 Miniseries Episode 7: Anosmia - What’s Currently Known

This episode was recorded on March 25, 2020.

Guest:  Erin K. O'Brien, M.D. (@ErinOBrienMD)

Host: Amit K. Ghosh, M.D., M.B.A. (@AmitGhosh006) 

Claim credit here: https://ce.mayo.edu/covid19podcast

What’s currently known about anosmia as a symptom of COVID-19 infection? Should we be using it as a screening tool? What causes it to occur when someone is infected with SARS-CoV-2 and what’s the prevalence in symptomatic vs otherwise asymptomatic individuals? Dr. Erin O’Brien gives an up-to-date overview of current reports, treatment options, and what you need to know about anosmia.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

COVID-19 Miniseries Episode 6: Mayo Clinic Q&A - The Latest Updates

Guest:  Greg Poland, MD (@drgregpoland)

Host: Tom Shives, MD and Tracy McCray (@TracyMcCray)

Claim credit for this episode at https://ce.mayo.edu/covid19podcast

On today's Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious disease expert and head of Mayo Clinic's Vaccine Research Group, shares the latest information on the COVID-19 pandemic. 

Dr. Poland discusses the importance of testing for SARS-CoV-2, work being done on antiviral medications; and how long social distancing might need to last, emerging reports of loss of smell in survivors, and the use of azithromycin and hydroxychloroquine.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Answering any Question You’ve Ever Had About Liver Function Testing

Guest: John J. Poterucha, M.D.

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

You can think of liver functions tests as falling into two buckets – markers of inflammation and perturbation and markers of liver function. Dr. John Poterucha answers any question you’ve ever had about liver function testing, including how to interpret the results plus when and what additional testing may need to be ordered as follow up.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Mayo Clinic Q&A: Coping with Uncertainty

This episode is shared from Mayo Clinic Q&A.

Guest: Beth Rush, PhD

Host: Tom Shives, MD and Tracy McCray (@TracyMcCray)

We are in the midst of uncertain times. Dr. Beth Rush, a Mayo Clinic neuropsychologist, shares tips for you and your patients about coping with uncertainty by creating a structured schedule. Listen in as she shares more tips for taking care of your mental health and finding comfort amid the uncertainty.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Mayo Clinic Q&A: Inflection Point

This episode is shared from Mayo Clinic Q&A and was recorded on March 19, 2020.

Guest: Greg Poland, MD

Host: Tom Shives, MD and Tracy McCray

Have we acted sufficiently to flatten the curve? When will we know? What does effective safe isolation look like?

Infectious diseases expert Dr. Gregory Poland, a Mayo Clinic infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group, answers new questions on COVID-19. How are we as a nation faring? What do you do when someone in your house is sick? 

Dr. Poland discusses preventive measures to stop the spread of the virus, what to do if you do get sick, and the potential for effective treatments and a vaccine.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Mayo Clinic Q&A: Isolation and Flattening the Curve

This episode is shared from Mayo Clinic Q&A and was recorded March 18, 2020.

Guest: Clayton T. Cowl, M.D., M.S. (@ChestPresident) 

Host: Tom Shives, M.D. and Tracy McCray

In epidemiology, the idea of slowing a virus' spread so that fewer people need to seek treatment at any given time is known as "flattening the curve." It's a phrase you've likely heard in the news, and it is an important goal for governments and health care leaders during the COVID-19 pandemic.

On the Mayo Clinic Q&A podcast Dr. Clayton Cowl, chair of Mayo Clinic's Division of Preventive, Occupational and Aerospace Medicine, explains how isolation can stop a spike in the number of new coronavirus cases. 

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd. 

Opioid Edition 9: Monitoring and Considerations for Tapering

Guest: Halena M. Gazelka, M.D. (@hmgazelkamd) 

Host: Tracy McCray

Episode 1 of 10: Dr. Halena Gazelka, an anesthesiologist boarded in pain and palliative medicine at Mayo Clinic in Rochester, talks about best practices for Opioid Monitoring and Considerations for Tapering. This podcast is brought to you by the Opioid conference held each year as a part of Mayo Clinic’s Continuing Medical Education.

Claim CME credit at ce.mayo.edu/opioidpc. This episode is required to be compliant with controlled substance prescribing guidelines in the state of Minnesota.

Episode transcript: https://mcdn.podbean.com/mf/web/hu4nsg/Ep_26-Opioid_Edition_9_Monitoring_and_Considerations_for_Tapering.pdf

Mayo Clinic Q&A: Taking Precautions in Long Term Care Facilities

This episode is shared from Mayo Clinic Q&A and was recorded March 17^th, 2020. 

Guest: Brandon P. Verdoorn, M.D.

Host: Tom Shives, MD and Tracy McCray

Long-term care facilities are taking steps to prepare and respond to the COVID-19 (coronavirus) outbreak. With guidance from the Centers for Disease Control and Prevention and the Centers for Medicare and Medicaid Services, long-term care facilities are restricting visitors in most cases.

On the Mayo Clinic Q&A podcast, Dr. Brandon Verdoorn, a Mayo Clinic geriatrician and medical director of Charter House, a continuing care retirement community affiliated with Mayo Clinic in Rochester, explains how staff are taking steps to keep residents safe and prevent spread of the coronavirus.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Mayo Clinic Q&A: Current Blood Supply Needs During the COVID-19 Pandemic

This episode is shared from Mayo Clinic Q&A and was recorded March 16^th, 2020.

Guest: Justin Kreuter, MD (@KreuterMD)

Host: Dr. Tom Shives and Tracy McCray

With recommendations to stay home during the COVID-19 pandemic, the U.S. now has a critical blood shortage. Blood donation collections have plummeted due to canceled blood drives and concerns about being out in the community. Almost half of U.S. blood collectors are reporting that they only have a two-day supply or less of blood products.

On today's Mayo Clinic Q&A podcast, Dr. Justin Kreuter, transfusion medicine specialist with the Mayo Clinic Blood Donor Center, explains how new blood donors are needed to step up and fill the void.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Demystifying Polycystic Ovary Syndrome

Guest: Alice Y. Chang, M.D. (@AliceChangMDMSc)

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

Polycystic Ovary Syndrome (PCOS) has a prevalence of between 5-10% American women of child-bearing age. With a variety of symptoms, different diagnosis methods, misunderstood criterion, and both genetic and environmental causes, PCOS can be easily missed, especially in patients whose symptoms have developed sporadically. Alice Y. Chang, M.D., breaks down this complicated condition, including treatment strategies based on the patient’s primary concern related to the disease.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

Deeper Dive:

• Ferriman-Gallwey Hirsutism Scoring System: https://education.endocrine.org/ferriman-gallwey-hirsutism-system

Opioid Edition 8: Family & Patient Counseling

Guest: Holly L. Geyer, M.D.

Host: Tracy McCray

Episode 8 of 10: What legal and ethical obligations do physicians have when prescribing opioids? How can we address systemic issues that need improvement? Dr. Holly Geyer, an internal medicine physician at Mayo Clinic in Arizona, shares her thoughts on what is currently being done to combat the opioid crisis and what additional steps can be taken to make a difference.

Claim CME credit at ce.mayo.edu/opioidpc.

Episode transcript: https://mcdn.podbean.com/mf/web/jit3rx/Ep_22-Opioid_Edition_8_Family_Patient_Counseling.pdf

Hand and Wrist Disorders

Guest: Peter C. Amadio, M.D. (@AmadioPeter)

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

Dr. Peter Amadio discusses carpal tunnel, de Quervain's tenosynovitis, and others hand and wrist conditions and gives a few key pearls for helping your patients control symptoms and when to consider surgery.

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

COVID-19 Miniseries Episode 5: SARS-CoV-2 and The Valley of Death

Episode Recorded March 5, 2020

To claim credit click here: https://ce.mayo.edu/covid19podcast

Guest: Gregory A. Poland, M.D. (@drgregpoland)

Host: Colin M. Bucks, M.D.

Why are we seeing very different severity and mortality rates as COVID-19 moves from country to country? Where are we at currently in regard to a COVID-19 vaccine? What does the pathway look like moving forward? Dr. Greg Poland lays out what you need to know about immunity and coronaviruses.  

Watch Dr. Poland teach Jimmy Kimmel and Guillermo how to wash their hands:

https://youtu.be/sJfsyhQ0oBs

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

For the most up to date COVID-19 information:

• CDC: https://www.cdc.gov/coronavirus/2019-ncov/index.html
• WHO: https://www.who.int/emergencies/diseases/novel-coronavirus-2019

Opioid Edition 7: Treating Opioid Addiction

Guest: Holly L. Geyer, M.D.

Host: Tracy McCray

Episode 7 of 10: Dr. Holly Geyer, an internal medicine physician, who serves on the Opioid Stewardship Program at Mayo Clinic in Arizona, discusses issues of dependency and addiction. What’s the difference between dependency and addiction? 

Claim CME credit at ce.mayo.edu/opioidpc.

Episode transcript: https://mcdn.podbean.com/mf/web/xvt7i9/Ep_21-Opioid_Edition_7_Treating_Opioid_Addiction.pdf